Profile: Compugen, Ltd. is a genomics-based drug and diagnostic discovery company. Our therapeutics programs consist of therapeutic candidates that have been initially predicted in silico, utilizing a proprietary discovery engine and then successfully demonstrated functional activity in vitro & in vivo. Our therapeutic product includes discovery engine that focuses on novel splice variants of known, clinically-related protein drugs or drug targets, and new discovery engines like the GPCR ligand discovery platform. Our areas of research include identification of novel GPCR peptide ligands, disease associated conformation peptide blockers, targets for monoclonal antibodies, new indications for existing drugs, drug response genomic markers and pathway kinetic simulation.